|
Volumn 20, Issue 11 Suppl 2, 2010, Pages
|
Optimally debulked stage III ovarian cancer: intraperitoneal or intravenous chemotherapy?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
PACLITAXEL;
CANCER STAGING;
FEMALE;
HUMAN;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
METHODOLOGY;
OVARY TUMOR;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
ANTINEOPLASTIC AGENTS;
CARBOPLATIN;
FEMALE;
HUMANS;
INJECTIONS, INTRAPERITONEAL;
INJECTIONS, INTRAVENOUS;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
MLCS;
MLOWN;
|
EID: 79952279785
PISSN: None
EISSN: 15251438
Source Type: Journal
DOI: 10.1111/igc.0b013e3181f60d26 Document Type: Review |
Times cited : (5)
|
References (0)
|